(S)-2-(FMOC-AMINO)-4-CYANOBUTANOIC ACID, 95.0%, 250mg

(S,S,S)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a:3,4-a']dinaphthalen-4-yl)bis(1-phenylethyl)amine>98.0%(HPLC)200mg

Methyl 2-methyl-5-nitrobenzoate, 95.0%, 100g

4-Fluoro-3-formylphenylboronic acid, 95.0%, 100g

4-(5-Nitropyridin-2-yl)morpholine, 95.0%, 100g

1-Phenyl-1H-pyrazole-5-carboxylic acid, 95.0%, 25g

2-Bromo-6-chlorobenzaldehyde, 95.0%, 500g

4-Imidazol-1-yl-butylamine, 97.0%, 1g

3-(N-Benzylsulfamoyl)-4-bromo-N-(4-bromophenyl)benzamide, 98%, 100mg

3-Bromo-4-methylbenzenesulfonamide, 95.0%, 10g

tert-Butyl 4-(2-iodoethyl)piperidine-1-carboxylate, 95%, 5g

Proteinasa K, 500 mg, en vial de vidrio de 30 ml

6-TERT-BUTYL 1-METHYL 6-AZASPIRO[2.5]OCTANE-1,6-DICARBOXYLATE, 95.0%, 5g